[Infection control for the treatment of XXXX : a survey of the Kyushu Hematology Organization for Treatment Study Group (K-HOT)].

@entity1 @entity1033 @entity8 @entity1261 @entity799 @entity6494 @entity19141 @entity1583 @entity378
The Kyushu Hematology Organization for Treatment Study Group (K-HOT) consisted of 22 institutions specializing in hematology in Kyushu. This study is aimed at reviewing the daily practice of infection control for the treatment of @entity1583 in our group. Nominal questionnaires were mailed to the hematology department in each institution from November 2001 to April 2002. For the first general surveys, 19 of 22 (86%) institutions responded. The second survey was mailed to the 19 respondents and 17 answered the detailed questionnaires with a response rate of 89%. Prophylactic use of @entity799 (ST) against @entity19141 carinii and anti-mycobacterial drugs in @entity1 who had a history of @entity378 was routine especially for @entity1 with @entity6494 ( @entity6494 ). Furthermore, the neutrophil counts to start a @entity1261 appeared to be high in @entity6494 as compared with other @entity1583 . In the setting of autologous @entity8 ( @entity8 ), prophylactic use of @entity1033 , immunoglobulin and ST was not routine and was reduced in duration, if used at all, as compared with allogeneic @entity8 . For allogeneic @entity8 , the cumulative dose of immunoglobulin significantly varied from institutions to institutions. The benefit of this study is the ability to recognize practical management patterns for infection control.
